pentobarbital has been researched along with Blindness in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hollwich, F | 1 |
Dieckhues, B | 1 |
Overton, DA | 1 |
2 other studies available for pentobarbital and Blindness
Article | Year |
---|---|
[Ocular light perception and metabolic activity of the liver (author's transl)].
Topics: Animals; Bilirubin; Blindness; Cataract; Cataract Extraction; Chemical and Drug Induced Liver Injury | 1974 |
Visual cues and shock sensitivity in the control of T-maze choice by drug conditions.
Topics: Animals; Blindness; Cues; Discrimination Learning; Electroshock; Male; Pentobarbital; Rats; Visual P | 1968 |